Literature DB >> 30725275

Non-small cell lung cancer with pathological complete response: predictive factors and surgical outcomes.

Hidenao Kayawake1,2, Norihito Okumura3, Keiji Yamanashi1, Ayuko Takahashi1, Satoshi Itasaka4, Hiroshige Yoshioka5, Takashi Nakashima1, Tomoaki Matsuoka1.   

Abstract

OBJECTIVES: When induction therapy followed by surgery for locally advanced non-small cell lung cancer results in pathological complete response, the prognosis is excellent; however, relapses can occur. We analyzed the predictive factors for achieving pathological complete response and reviewed the clinicopathological features and surgical outcomes of locally advanced non-small cell lung cancer with pathological complete response.
METHODS: Between March 2005 and January 2015, 145 resections after induction therapy for locally advanced non-small cell lung cancer were performed; 38 cases achieved pathological complete response. Predictive factors for achieving pathological complete response were analyzed, and the clinicopathological features and surgical outcomes of 38 cases with pathological complete response were retrospectively reviewed.
RESULTS: Of 145 patients, 98 underwent induction chemoradiation and 47, induction chemotherapy. Squamous cell carcinoma occurred most frequently (n = 64), followed by adenocarcinoma (n = 53). Only squamous cell carcinoma was positively associated with achieving pathological complete response (p = 0.009). Of 38 patients with pathological complete response, 33 were men and the mean age was 67.0 ± 6.3 years; the clinical stages were IIA (n = 3), IIB (n = 2), IIIA (n = 26), and IIIB (n = 3). One patient died within 30 days post-surgery (2.6%). Eight recurrences occurred during the follow-up period; brain metastasis occurred most frequently. The 5-year overall and recurrence-free survival rates were 79.5% and 72.6%, respectively.
CONCLUSIONS: Squamous cell carcinoma was identified as a positive predictive factor for achieving pathological complete response. Among patients undergoing lung cancer surgery after induction therapy with pathological complete response, brain metastasis occurred most frequently.

Entities:  

Keywords:  Induction therapy; Lung cancer; Pathological complete response; Squamous cell carcinoma; Surgical outcome

Mesh:

Year:  2019        PMID: 30725275     DOI: 10.1007/s11748-019-01076-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  2 in total

1.  Real-World Effectiveness and Prognostic Factors Analysis of Stages I-III Non-Small Cell Lung Cancer Following Neoadjuvant Chemo-Immunotherapy or Neoadjuvant Chemotherapy.

Authors:  Zuo Liu; Zhaoming Gao; Mengzhe Zhang; Xiaofei Wang; Jialin Gong; Shuai Jiang; Zhenfa Zhang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-11-15       Impact factor: 1.889

2.  Association of Pathologic Complete Response and Long-Term Survival Outcomes Among Patients Treated With Neoadjuvant Chemotherapy or Chemoradiotherapy for NSCLC: A Meta-Analysis.

Authors:  Samuel Rosner; Chunnan Liu; Patrick M Forde; Chen Hu
Journal:  JTO Clin Res Rep       Date:  2022-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.